Panagora Asset Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.6K Buy
+24,143
New +$47.1K ﹤0.01% 1225
2019
Q1
– Sell
-1
Closed -$17K – 2552
2018
Q4
$17K Buy
+1
New +$57.4K ﹤0.01% 2244
2018
Q3
– Hold
0
– – – 2126
2018
Q2
– Hold
0
– – – 2111
2018
Q1
– Hold
0
– – – 2039
2016
Q1
– Hold
0
– -$31K – 2328
2015
Q4
– Hold
0
– – – 2086
2015
Q3
– Hold
0
– – – 2057
2014
Q2
– Hold
0
– -$500K – 2369
2014
Q1
– Hold
0
– – – 1416

Other funds holding PALI

Panagora Asset Management's PALI Position: Q3 2026 in Review

Panagora Asset Management opened a new position in Palisade Bio (PALI) in Q3 2026: 24,143 shares worth $32.6K. The stake represents ﹤0.01% of the portfolio and ranks #1225 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in PALI as recently as Q4 2018.

Panagora Asset Management first reported a position in PALI in Q4 2018 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Panagora Asset Management held 24,143 shares of Palisade Bio worth $32.6K as of Q3 2026.
  • Palisade Bio was a new Panagora Asset Management position in Q3 2026.
  • Palisade Bio made up ﹤0.01% of Panagora Asset Management's portfolio in Q3 2026, its #1225 holding.
  • Panagora Asset Management first reported a position in Palisade Bio in Q4 2018 and has held it in 2 quarters since.
  • 66 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.